HCM
CHTP

Highbridge Capital Management’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

Highbridge Capital Management’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-111,614
Closed -$335K – 1573
2013
Q3 		$335K Buy
+111,614
New +$321K ﹤0.01% 1013

Other funds holding CHTP

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Highbridge Capital Management's CHTP Position: Q4 2013 in Review

Highbridge Capital Management sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q4 2013, closing a stake of 111,614 shares — an estimated $335K sold.

Highbridge Capital Management first reported a position in CHTP in Q3 2013 and held it in 1 quarter. The position peaked at $335K in Q3 2013. 78 funds tracked by Wall St. Rank hold CHTP as of Q4 2013.

  • Highbridge Capital Management reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q4 2013 after selling out during the quarter.
  • Highbridge Capital Management sold 111,614 CHELSEA THERAPEUTICS INT'L LTD shares in Q4 2013, an estimated $335K.
  • Highbridge Capital Management first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q3 2013 and held it in 1 quarter.
  • Highbridge Capital Management's CHELSEA THERAPEUTICS INT'L LTD position peaked at $335K in Q3 2013.
  • 78 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q4 2013.

Based on Highbridge Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.